| Autor: |
Allen Green, Yu-Min P. Shen, Andrew T. Nelson, Ravi Sarode, Ibrahim F. Ibrahim, Jing Cao, Sajjad Afraz, Sean G. Yates |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Annals of hematologyReferences. 101(12) |
| ISSN: |
1432-0584 |
| Popis: |
Acquired von Willebrand syndrome (AVWS) is a rare hematologic disorder characterized by quantitative or qualitative defects of von Willebrand factor (vWF), a protein crucial for normal hemostasis. AVWS has been described in association with several pathologic entities with varied mechanisms. Among these, lymphoproliferative disorders are the most common, with monoclonal gammopathy of undetermined significance (MGUS) being the most frequently reported. AVWS in this setting is commonly associated with the development of bleeding that is clinically challenging to manage due to accelerated clearance of vWF, limiting the utility of many conventional treatment modalities such as DDAVP or vWF/FVIII. We report a case of a 43-year-old male who was sent to our institution for new-onset easy bruising and laboratories concerning for von Willebrand disease (vWD). Further diagnostic workup revealed evidence of an IgG monoclonal gammopathy and findings suggestive of vWF inhibition. Ultimately, he was found to have monoclonal gammopathy of clinical significance (MGCS)-associated AVWS refractory to conventional treatment but responsive to lenalidomide and dexamethasone. This case suggests that lenalidomide may be suitable for patients with AVWS secondary to MGCS. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink